Short-term continuous subcutaneous insulin infusion combined with insulin sensitizers rosiglitazone, metformin, or antioxidant alpha-lipoic acid in patients with newly diagnosed type 2 diabetes mellitus - Huang, Z; Wan, X; Liu, J (Diabetes Technol Therap, 2013)
et al.